Skip to content

Treatment of intracranial arterial occlusion, imaging features of vascular architecture and prognosis

Treatment of intracranial arterial occlusion, imaging features of vascular architecture and prognosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054480
Enrollment
Unknown
Registered
2021-12-18
Start date
2021-12-17
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial artery occlusion

Interventions

case series:None

Sponsors

Beijing Tiantan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients of intracranial artery occlusion.

Exclusion criteria

Exclusion criteria: 1. There is more than 70% stenosis in the same vascular bed except for the responsible lesion; 2. History of cerebral hemorrhage, subarachnoid hemorrhage, subdural hemorrhage or epidural hemorrhage within 6 weeks; 3. Previous intracranial arterial angioplasty or stenting; 4. There are concurrent intracranial tumors, aneurysms or intracranial arteriovenous malformations; 5. The patient cannot receive dual antiplatelet therapy due to known diseases; 6. Known contraindications to heparin, aspirin, clopidogrel, ticagrelor, rapamycin, anesthesia and contrast agents; 7. Hemoglobin is less than 10g/dl and platelet count is less than 100x10^9; 8. Severe liver and kidney dysfunction; 9. International normalized ratio (INR) greater than 1.5 (irreversible), with uncorrectable bleeding factors; 10. Major surgery performed within the past 30 days or planned within the next 90 days; 11. Renal artery, iliac artery or coronary artery stenosis requiring simultaneous intervention; 12. The life expectancy due to the disease is less than 1 year; 13. Pregnant or lactating patients; 14. Unable to complete follow-up due to cognitive, emotional or mental illness; 15. The investigator believes that the patient is not suitable for intracranial artery stent endovascular treatment; 16. Other studies that conflict with this study have been enrolled.

Design outcomes

Primary

MeasureTime frame
Brain MRI;

Countries

China

Contacts

Public ContactMa Ning

Beijing Tiantan Hospital

maning_03@hotmail.com+86 10 59978857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026